Quality of life in small-scaled homelike nursing homes: An 8-month controlled trial

Jeroen S. Kok*, Marjan M.A. Nielen, Erik J.A. Scherder

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review


Background: Quality of life is a clinical highly relevant outcome for residents with dementia. The question arises whether small scaled homelike facilities are associated with better quality of life than regular larger scale nursing homes do. Methods: A sample of 145 residents living in a large scale care facility were followed over 8months. Half of the sample (N=77) subsequently moved to a small scaled facility. Quality of life aspects were measured with the QUALIDEM and GIP before and after relocation. Results: We found a significant Group x Time interaction on measures of anxiety meaning that residents who moved to small scale units became less anxious than residents who stayed on the regular care large-scale units. No significant differences were found on other aspects of quality of life. Conclusions: This study demonstrates that residents who move from a large scale facility to a small scale environment can improve an aspect of quality of life by showing a reduction in anxiety.

Original languageEnglish
Article number38
Pages (from-to)1-8
Number of pages8
JournalHealth and Quality of Life Outcomes
Publication statusPublished - 27 Feb 2018


The study was approved by the Ethical Committee of the department of Psychology of the University of Groningen, the Netherlands (no. PPO008093), registered 3 June 2009. The legal representatives of the residents provided written informed consent and the residents verbal consent. In case the resident expressed either verbally or non-verbally the wish to end the examination, the examination was directly terminated.

FundersFunder number
Rijksuniversiteit Groningen


    • Dementia
    • Long term care
    • Nursing home
    • Quality of life


    Dive into the research topics of 'Quality of life in small-scaled homelike nursing homes: An 8-month controlled trial'. Together they form a unique fingerprint.

    Cite this